Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

CHOKSI LABORATORIES LTD.

NSE : NABSE : 526546ISIN CODE : INE493D01013Industry : Hospital & Healthcare ServicesHouse : Private

BSE124.002.9 (+2.39 %)

PREV CLOSE ( ) 121.10

OPEN PRICE ( ) 142.95

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 2891

TODAY'S LOW / HIGH ( )123.00 142.95

52 WK LOW / HIGH ( ) 60.21236.7

NSE

This Company is not listed in NSE

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 29-01 1993

Management Info

Sunil Choksi - Chairman Sunil Choksi - Managing Director

Registered Office

Address Survey No 9/1,Near Tulsiyana Industrial Park,Gram Kumerdi,
Indore,
Madhya Pradesh-453555

Phone 0731-3501112

Email compliance_officer@choksilab.com

Website www.choksilab.in

Registrars Details

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE

NEWS

14Nov Choksi Laboratories submits unaudited
Pursuant to Regulation 30 & 33 of the SEBI (Listing Obligations and..

25Apr Choksi Laboratories informs about disc
Choksi Laboratories has confirmed that it is not identified as a Large C..

15Feb Choksi Laboratories informs about news
Pursuant to Regulation 30 read with Schedule III Part A (A) and in compl..

22Oct Choksi Laboratories informs about issu
Choksi Laboratories has informed that shareholders has reported the misp..

14Oct Choksi Laboratories informs about comp
Choksi Laboratories has informed that it enclosed compliance certificate..

Financials

Rs. in Millions

	QTR Sep 25	ANNUAL 25
Net Profit	2.40999999999999	15.22
Gross Profit	5.61999999999999	21.52
Operating Profit	29.43	113
Net Sales	111.17	418.49

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Thyrocare Tech. (BSE) 458.45 (6.06%)	M.Cap ( in Cr)7283.24
Dr Agarwals Eye Hsp (BSE) 5463.70 (0.14%)	M.Cap ( in Cr)2633.89
Sharma Hospitals (BSE) 139.00 (4.24%)	M.Cap ( in Cr)45.64
Fortis Healthcare (BSE) 873.85 (0.49%)	M.Cap ( in Cr)65832.35
Artemis Medicare (BSE) 283.90 (0.87%)	M.Cap ( in Cr)4475.49

Shareholding Pattern

	NON-INSTITUTION	62.83%
	PROMOTERS	31.48%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

CHOKSI LABORATORIES LTD.